Lack of Efficacy of Topical Latanoprost in the Treatment of Eyebrow Alopecia Areata

    Elizabeth M. Ross, Chanted Bolduc, F. Harvey Lui, Jerry Shapiro
    Image of study
    TLDR Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.
    In 2005, a 16-week, randomized, right-left, investigator-blinded study was conducted on 11 adults with severe eyebrow alopecia areata (AA) to assess the therapeutic potential of latanoprost, a prostaglandin F2a analog. The participants were required to treat one eyebrow with topical latanoprost (3 µg) for 12 hours daily over 12 weeks. Of the 11 patients, 8 completed the study. One patient withdrew due to reported treatment-related side effects. The results showed that the use of latanoprost daily for 12 weeks was ineffective in producing significant regrowth in 7 patients. One patient did have a positive response, but this occurred bilaterally and was likely a result of institution of prednisone therapy during the treatment period for an unrelated problem. The study concluded that treatment of extensive eyebrow AA with topical latanoprost is well tolerated but an ineffective means for producing dense regrowth.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 207 results

      community All Drugs in Clinical Trials in 2023

      in Research/Science  71 upvotes 3 years ago
      12 companies having drugs or therapies in clinical trials during 2023, with various molecules and phases of trial; the probability that some may fail; and progress being made in the field.

      community Medications that cause extra hair growth

      in Research/Science  123 upvotes 2 years ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community DLQ01: A Better "Minoxidil" PGF2a synthetic analogue.

      in Research/Science  3 upvotes 1 year ago
      DLQ01, a prostaglandin F2α analog, shows promise for hair growth by directly stimulating PGE2/PGF receptors without needing conversion, and can be combined with minoxidil and retinoids like tretinoin for enhanced effectiveness. Minoxidil's efficacy may be reduced by COX-1 inhibitors, but using prostaglandin analogs like Latanoprost or Bimatoprost can help maintain its effectiveness.

    Related Research

    7 / 7 results